Advertisement

Topics

Nationwide Fund Advisors Has $342,000 Position in Achillion Pharmaceuticals, Inc.

05:50 EDT 3 Jul 2017 | Topix

Nationwide Fund Advisors decreased its position in shares of Achillion Pharmaceuticals, Inc. by 6.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission . The institutional investor owned 81,140 shares of the biopharmaceutical company's stock after selling 5,139 shares during the period.

Original Article: Nationwide Fund Advisors Has $342,000 Position in Achillion Pharmaceuticals, Inc.

NEXT ARTICLE

More From BioPortfolio on "Nationwide Fund Advisors Has $342,000 Position in Achillion Pharmaceuticals, Inc."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...